Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;14(4):463-8.
doi: 10.1093/icvts/ivr144. Epub 2012 Jan 9.

Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation

Affiliations

Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation

Miralem Pasic et al. Interact Cardiovasc Thorac Surg. 2012 Apr.

Abstract

There is no established strategy of how and when to treat coronary artery disease (CAD) in patients referred for transcatheter aortic valve implantation (TAVI). Simultaneous, single-stage treatment of both pathologies is a possible solution. We report our initial results of simultaneously performed transapical TAVI and elective percutaneous coronary interventions (PCI) in high-risk patients with severe aortic valve stenosis. Between April 2008 and July 2011, a total of 419 patients underwent transapical TAVI. Combined elective PCI and TAVI were performed in 46 (11%) patients. Only the most significant coronary lesion or lesions were treated. Technical success of the combined approach was 100%. The mean count of implanted stents per patient was 1.6 ± 1.0 (range, 1-5 stents). The 30-day mortality rates in the PCI and TAVI group was 4.3%. Survival at 12, 24 and 36 months of the PCI and TAVI group 87.1 ± 5.5, 69.7 ± 10.3 and 69.7 ± 10.3%, respectively. The results showed that the single-stage approach with combined elective PCI and TAVI is feasible and safe. It has become our primary choice for treatment of high-risk patients with severe aortic valve stenosis and CAD.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Percutaneous coronary intervention of the proximal dominant right coronary artery (a–c). Note the already implanted Edwards Sapien valve.
Figure 2:
Figure 2:
Sequences of combined transapical aortic valve implantation (a–c) and percutaneous coronary intervention (d–f) of the proximal left anterior descending artery (arrow) in a 98-year old male patient.
Figure 3:
Figure 3:
Sequences of combined transapical aortic valve implantation (a–c) and percutaneous coronary intervention (d–f) of the mid left anterior descending artery (arrow) in a 95-year old female patient.
Figure 4:
Figure 4:
Kaplan–Meier probability of survival after combined percutaneous coronary intervention and transapical aortic valve implantation.

References

    1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. - PubMed
    1. Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, et al. PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32:148–57. - PMC - PubMed
    1. Masson JB, Lee M, Boone RH, Al Ali A, Al Bugami S, Hamburger J, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:165–73. - PubMed
    1. Webb JG. Strategies in the management of coronary artery disease and transcatheter aortic valve implantation (Editorial) Catheter Cardiovasc Interv. 2009;73:68. - PubMed
    1. Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol. 2011;100:311–6. - PubMed

MeSH terms